This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Monsanto’s Annual Pipeline Update Provides A Look Into Agriculture’s Future

Stocks in this article: MON

Monsanto Company’s (NYSE: MON) annual research and development update marks the company’s largest advancement of products to date. The agricultural company announced today a record 29 products progressed in its pipeline with five of those headed to the commercial marketplace. Monsanto’s advancements include products across all of its platforms, including breeding, biotechnology, and new technology areas such as Integrated Farming Systems ® and agricultural biologicals.

“Monsanto’s annual pipeline update provides a window into agriculture’s future – and, specifically, how breeding, biotechnology, biologicals and improved agronomics can meet the challenges of feeding a growing planet while using resources more efficiently,” said Robb Fraley, Ph.D., Monsanto’s chief technology officer. “From rural communities in America, to the plains of Sub-Saharan Africa, our scientists and breeders are working to provide farmers with innovations that can help them get the most out of every acre. I am particularly proud as this year’s advancements highlight the breadth of our R&D efforts and the truly integrated approach we are taking in order to deliver a total system of solutions that can offer additional choice for our farmer customers.”

Pipeline Highlights

  • Nearly 30 of the company’s more than 70 pipeline projects advanced phases this year.
  • A record five products graduated from the pipeline, including Intacta RR2 PRO soybeans, FieldScripts ® variable rate seeding in corn and Root-Knot Nematode Resistance within the cotton breeding pipeline.
  • Some of the most breakthrough progress was delivered from the company’s newest technology platforms, including more than 10 advancements across its Integrated Farming Systems ® and agricultural biologicals platforms.
  • In addition to the 29 project advancements, Monsanto will have three projects in its Ground Breakers ® on-farm testing program this year. Projects include Vistive ® Gold soybeans, Roundup Ready 2 Xtend soybeans and Bollgard ® II XtendFlex cotton.

“Monsanto is headed in the right direction with science-based approaches and new technologies for farmers,” said Jeff Frank, a FieldScripts ® Ground Breakers ® farmer in Auburn, Iowa. “The data driven, scientific technologies Monsanto is developing are things we’ve never had before. As farmers, we have to take advantage of any opportunity we can to increase our yield potential. If we don’t think progressively, we won’t grow enough crops to feed a growing planet.”

Biotechnology Platform

Monsanto has a pipeline of biotechnology projects in development, including next-generation insect control and herbicide tolerance agronomic trait projects as well as yield and stress work in collaboration with BASF Plant Science. This year’s nine biotechnology advancements include the launch of Intacta RR2 PRO soybeans and next-generation products like SmartStax ® PRO corn (formally Corn Rootworm III), Second-Generation Intacta RR2 PRO soybeans, Third-Generation Herbicide Tolerant soybeans and Bollgard ® III cotton.

Breeding Platform

In addition to annual germplasm improvements, this year’s breeding pipeline advanced seven projects within the industry’s most-advanced disease resistance breeding program. Project highlights include enhanced resistance to Anthracnose Stalk Rot and Gray Leaf Spot in corn and Soybean Cyst Nematode, as well as Phytophthora Resistant Peppers, Bacterial Wilt Resistant Tomatoes and Downy Mildew Resistant Lettuce.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,815.80 +37.65 0.21%
S&P 500 2,066.60 +5.37 0.26%
NASDAQ 4,752.8210 +4.4250 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs